{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:39:56Z","timestamp":1790239196657,"version":"4.1.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020469","name":"Universidad Cient\u00edfica del Sur","doi-asserted-by":"publisher","award":["POS-50-2024-00696"],"award-info":[{"award-number":["POS-50-2024-00696"]}],"id":[{"id":"10.13039\/100020469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bloodstream infections (BSIs) caused by carbapenemase-producing Enterobacterales (CPE) are associated with increased mortality rates. However, limited data exist in Latin America, particularly in regions where blaNDM is predominant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of adult inpatients with Escherichia coli or Klebsiella pneumoniae BSI at a Peruvian referral hospital between 2020 and 2023. Patients were classified as CPE or non-CPE based on molecular testing. The outcome was 30-day all-cause mortality. Multivariable Cox regression was used to identify independent predictors of mortality, adjusting for confounders selected via a directed acyclic graph.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 506 patients, 97 (19.2%) had CPE BSIs, predominantly blaNDM (63.9%) and blaKPC (36.1%). Overall, the 30-day mortality rate was 27.3%, significantly higher in the CPE group (52.6% vs 21.3%; P &amp;lt; .001). In multivariable analysis, CPE infection remained independently associated with increased mortality (adjusted hazard ratio [aHR] 1.88; 95% CI 1.19\u20132.96). Other predictors included age \u226560 years (aHR 1.53), septic shock (aHR 2.93), pneumonia (aHR 1.70), and immunosuppression (aHR 1.72). Among CPE subtypes, Klebsiella pneumoniae Carbapenemase (KPC)-producers conferred the highest mortality risk (aHR 2.64). Concordant empirical antibiotic therapy was not significantly protective after adjustment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CPE BSIs were independently associated with increased 30-day mortality, with KPC-producing K pneumoniae posing the greatest risk. Despite the predominance of New Delhi Metallo-\u03b2-Lactamase (NDM) in our setting, these findings emphasize the clinical severity associated with different carbapenemase types, and the need to tailor interventions accordingly. Strengthening molecular surveillance and ensuring timely access to effective therapies remain critical priorities in NDM-endemic regions, such as Peru.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf729","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T13:12:45Z","timestamp":1764335565000},"source":"Crossref","is-referenced-by-count":7,"title":["Thirty-Day Mortality Associated With Carbapenemase-Producing\n                    <i>Enterobacterales<\/i>\n                    Bloodstream Infections at a Referral Hospital in Peru, 2020\u20132023"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3823-4737","authenticated-orcid":false,"given":"Giancarlo","family":"P\u00e9rez-Lazo","sequence":"first","affiliation":[{"name":"Posgrado de Medicina, Facultad de Ciencias de la Salud, Universidad Cient\u00edfica del Sur , Lima ,","place":["Per\u00fa"]},{"name":"Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud , Lima ,","place":["Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Sandoval-Ahumada","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Guillermo Almenara Irigoyen National Hospital-EsSalud , Lima ,","place":["Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3676-243X","authenticated-orcid":false,"given":"Carlos","family":"Tairo-Cerron","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud , Lima ,","place":["Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ballena-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud , Lima ,","place":["Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Soto-Febres","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud , Lima ,","place":["Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-2423","authenticated-orcid":false,"given":"Steev","family":"Loyola","sequence":"additional","affiliation":[{"name":"Posgrado de Medicina, Facultad de Ciencias de la Salud, Universidad Cient\u00edfica del Sur , Lima ,","place":["Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2025121011315096900_ofaf729-B1"},{"key":"2025121011315096900_ofaf729-B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","author":"Sati","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2025121011315096900_ofaf729-B3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2025121011315096900_ofaf729-B4","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/cid\/ciy642","article-title":"In-hospital medical costs of infections caused by carbapenem-resistant Klebsiella pneumoniae","volume":"67","author":"Huang","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B5","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/cid\/ciad100","article-title":"Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO network)","volume":"76","author":"Falcone","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B6","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10096-015-2379-9","article-title":"Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade","volume":"34","author":"Meletis","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025121011315096900_ofaf729-B7","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/ciad151","article-title":"Antibiotic consumption during the coronavirus disease 2019 pandemic and emergence of carbapenemase-producing Klebsiella pneumoniae lineages among inpatients in a Chilean hospital: a time-series study and phylogenomic analysis","volume":"77","author":"Allel","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B8","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/cid\/ciad260","article-title":"A 7-year Brazilian national perspective on plasmid-mediated carbapenem resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex and the impact of the coronavirus disease 2019 pandemic on their occurrence","volume":"77","author":"Kiffer","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2811.220415","article-title":"Increased detection of carbapenemase-producing Enterobacterales bacteria in Latin America and the Caribbean during the COVID-19 pandemic","volume":"28","author":"Thomas","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2025121011315096900_ofaf729-B10","doi-asserted-by":"crossref","first-page":"e00397","DOI":"10.1128\/AAC.00397-20","article-title":"Metallo-\u03b2-lactamases: structure, function, epidemiology, treatment options, and the development pipeline","volume":"64","author":"Boyd","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025121011315096900_ofaf729-B11","doi-asserted-by":"crossref","first-page":"e0154092","DOI":"10.1371\/journal.pone.0154092","article-title":"Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing Enterobacteriaceae in seven Latin American countries","volume":"11","author":"Villegas","year":"2016","journal-title":"PLoS One"},{"key":"2025121011315096900_ofaf729-B12","doi-asserted-by":"crossref","first-page":"e0182524","DOI":"10.1128\/spectrum.01825-24","article-title":"Emerging carbapenem-resistant Klebsiella pneumoniae in a tertiary care hospital in Lima, Peru","volume":"13","author":"Krapp","year":"2025","journal-title":"Microbiol Spectr"},{"key":"2025121011315096900_ofaf729-B13","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.26633\/RPSP.2020.61","article-title":"Panorama de las carbapenemasas en Per\u00fa","volume":"44","author":"Angles-Yanqui","year":"2020","journal-title":"Rev Panam Salud Publica"},{"key":"2025121011315096900_ofaf729-B14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4269\/ajtmh.22-0556","article-title":"Prevalence of antimicrobial resistance in gram-negative bacteria bloodstream infections in Peru and associated outcomes: VIRAPERU study","volume":"109","author":"Krapp","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"2025121011315096900_ofaf729-B15"},{"key":"2025121011315096900_ofaf729-B16"},{"key":"2025121011315096900_ofaf729-B17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025121011315096900_ofaf729-B18","doi-asserted-by":"crossref","first-page":"e0186822","DOI":"10.1128\/spectrum.01868-22","article-title":"Incidence and time-to-onset of carbapenemase-producing Enterobacterales (CPE) infections in CPE carriers: a retrospective cohort study","volume":"10","author":"Hoellinger","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2025121011315096900_ofaf729-B19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/pathogens12020212","article-title":"Clinical and epidemiological characteristics of persistent bacteremia: a decadal observational study","volume":"12","author":"Kitaya","year":"2023","journal-title":"Pathogens"},{"key":"2025121011315096900_ofaf729-B20","first-page":"1639","article-title":"Measuring appropriate antimicrobial use: attempts at opening the black box","volume":"63","author":"Spivak","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B21","doi-asserted-by":"crossref","first-page":"106126","DOI":"10.1016\/j.ijantimicag.2020.106126","article-title":"Clinical and microbiological analysis of risk factors for mortality in patients with carbapenem-resistant Enterobacteriaceae bacteremia","volume":"56","author":"Seo","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2025121011315096900_ofaf729-B22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13643-024-02695-x","article-title":"Efficiency of combination therapy versus monotherapy for the treatment of infections due to carbapenem-resistant gram-negative bacteria: a systematic review and meta-analysis","volume":"13","author":"Lai","year":"2024","journal-title":"Syst Rev"},{"key":"2025121011315096900_ofaf729-B23","volume-title":"Performance standards for antimicrobial susceptibility testing. 34th ed. CLSI supplement M100 (ISBN 978-1-68440-220-5 [print]; ISBN 978-1-68440-221-2 [electronic])","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2024"},{"key":"2025121011315096900_ofaf729-B24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/ice.2019.282","article-title":"Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: a systematic review and meta-analysis","volume":"41","author":"Budhram","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025121011315096900_ofaf729-B25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jgar.2024.03.020","article-title":"Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018\u20132022","volume":"37","author":"Wise","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"2025121011315096900_ofaf729-B26","doi-asserted-by":"crossref","first-page":"ofae631","DOI":"10.1093\/ofid\/ofae631.1549","article-title":"P-1372. Distribution and mechanisms of resistance among carbapenem-resistant Enterobacterales in Peru","volume":"12","author":"Reyes Quevedo","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2025121011315096900_ofaf729-B27","doi-asserted-by":"crossref","first-page":"ofae228","DOI":"10.1093\/ofid\/ofae228","article-title":"Deciphering the efficacy of \u03b2-lactams in the face of metallo-\u03b2-lactamase-derived resistance in Enterobacterales: supraphysiologic zinc in the broth is the culprit","volume":"11","author":"Abdelraouf","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025121011315096900_ofaf729-B28","doi-asserted-by":"crossref","first-page":"e0005222","DOI":"10.1128\/spectrum.00052-22","article-title":"Comparison of zinc concentrations in the broth of commercial automated susceptibility testing devices (Vitek 2, MicroScan, BD Phoenix, and Sensititre)","volume":"10","author":"Asempa","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2025121011315096900_ofaf729-B29","doi-asserted-by":"crossref","first-page":"e02019","DOI":"10.1128\/JCM.02019-20","article-title":"Variability in zinc concentration among Mueller-Hinton broth brands: impact on antimicrobial susceptibility testing of metallo-\u03b2-lactamase-producing Enterobacteriaceae","volume":"58","author":"Bilinskaya","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2025121011315096900_ofaf729-B30","doi-asserted-by":"crossref","first-page":"115505","DOI":"10.1016\/j.diagmicrobio.2021.115505","article-title":"Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia","volume":"101","author":"Hovan","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025121011315096900_ofaf729-B31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/cid\/ciw741","article-title":"Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B32","doi-asserted-by":"crossref","first-page":"e0266787","DOI":"10.1371\/journal.pone.0266787","article-title":"Virulence-associated genes analysis of carbapenemase-producing Escherichia coli isolates","volume":"17","author":"Jomehzadeh","year":"2022","journal-title":"PLoS One"},{"key":"2025121011315096900_ofaf729-B33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41598-023-51118-9","article-title":"Comparison of mortality rates in patients with carbapenem-resistant Enterobacterales bacteremia according to carbapenemase production: a multicenter propensity-score matched study","volume":"14","author":"Baek","year":"2024","journal-title":"Sci Rep"},{"key":"2025121011315096900_ofaf729-B34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/antibiotics8030122","article-title":"Present and future of carbapenem-resistant Enterobacteriaceae (CRE) infections","volume":"8","author":"Suay-Garc\u00eda","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"2025121011315096900_ofaf729-B35","doi-asserted-by":"crossref","first-page":"1167.e1","DOI":"10.1016\/j.cmi.2020.09.043","article-title":"Comparison of clinical outcomes of patients infected with KPC- and NDM-producing Enterobacterales: a retrospective cohort study","volume":"27","author":"Seo","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025121011315096900_ofaf729-B36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf259","article-title":"Carbapenem-resistant gram-negative bacilli bacteremia in Argentina (EMBARCAR): findings from a prospective, multicenter cohort study","author":"Balbuena","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B38","doi-asserted-by":"crossref","first-page":"ofaa461","DOI":"10.1093\/ofid\/ofaa461","article-title":"Epidemiology and risk factors associated with mortality in consecutive patients with bacterial bloodstream infection: impact of MDR and XDR Bacteria","volume":"7","author":"Santoro","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025121011315096900_ofaf729-B39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/cid\/ciad288","article-title":"International epidemiology of carbapenemase-producing Escherichia coli","volume":"77","author":"Boutzoukas","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025121011315096900_ofaf729-B40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/ice.2024.21","article-title":"Mortality associated with carbapenem resistance in Klebsiella pneumoniae bloodstream infection: a propensity score-matched study","volume":"45","author":"Wang","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025121011315096900_ofaf729-B41","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/jac\/dkad262","article-title":"Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape","volume":"78","author":"Giacobbe","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2025121011315096900_ofaf729-B42","doi-asserted-by":"crossref","first-page":"107449","DOI":"10.1016\/j.ijantimicag.2025.107449","article-title":"Epidemiology and outcomes associated with MBL-producing Enterobacterales: a systematic literature review","volume":"65","author":"Kanj","year":"2025","journal-title":"Int J Antimicrob Agents"},{"key":"2025121011315096900_ofaf729-B43","doi-asserted-by":"crossref","first-page":"e0265089","DOI":"10.1371\/journal.pone.0265089","article-title":"High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: a single centre retrospective cohort study","volume":"17","author":"Mas-Ubillus","year":"2022","journal-title":"PLoS One"},{"key":"2025121011315096900_ofaf729-B44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/23744235.2021.1963471","article-title":"Carbapenemase-producing Enterobacterales infections in COVID-19 patients","volume":"54","author":"Pintado","year":"2022","journal-title":"Infect Dis (Lond)"},{"key":"2025121011315096900_ofaf729-B45","doi-asserted-by":"crossref","first-page":"1355144","DOI":"10.3389\/fmed.2024.1355144","article-title":"Antimicrobial resistance in intensive care patients hospitalized with SEPSIS: a comparison between the COVID-19 pandemic and pre-pandemic era","volume":"11","author":"Falasca","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"2025121011315096900_ofaf729-B46","doi-asserted-by":"crossref","first-page":"e14066","DOI":"10.1590\/1414-431x2025e14066","article-title":"The extent of carbapenem-resistant encoding genes in Klebsiella pneumoniae from COVID-19 and non-COVID-19 patients in a tertiary care center, Saudi Arabia","volume":"58","author":"Al Bshabshe","year":"2025","journal-title":"Braz J Med Biol Res"},{"key":"2025121011315096900_ofaf729-B47","doi-asserted-by":"crossref","first-page":"100298","DOI":"10.1016\/j.infpip.2023.100298","article-title":"Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales bloodstream infections: a multicentre study","volume":"5","author":"Anton-Vazquez","year":"2023","journal-title":"Infect Prev Pract"},{"key":"2025121011315096900_ofaf729-B48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhin.2021.01.028","article-title":"Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilities","volume":"110","author":"Zhao","year":"2021","journal-title":"J Hosp Infect"},{"key":"2025121011315096900_ofaf729-B49","doi-asserted-by":"crossref","first-page":"e13855","DOI":"10.1111\/cts.13855","article-title":"Mortality factors and antibiotic options in carbapenem-resistant Enterobacterales bloodstream infections: insights from a high-prevalence setting with co-occurring NDM-1 and OXA-48","volume":"17","author":"Karnmueng","year":"2024","journal-title":"Clin Transl Sci"},{"key":"2025121011315096900_ofaf729-B50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40560-023-00650-x","article-title":"Mortality analysis among sepsis patients in and out of intensive care units using the Japanese nationwide medical claims database: a study by the Japan Sepsis Alliance study group","volume":"11","author":"Oami","year":"2023","journal-title":"J Intensive Care"},{"key":"2025121011315096900_ofaf729-B51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40560-023-00663-6","article-title":"Association between the timing of ICU admission and mortality in patients with hospital-onset sepsis: a nationwide prospective cohort study","volume":"11","author":"Ahn","year":"2023","journal-title":"J Intensive Care"},{"key":"2025121011315096900_ofaf729-B52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmi.2023.11.008","article-title":"Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)","volume":"30","author":"Paniagua-Garc\u00eda","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025121011315096900_ofaf729-B53","doi-asserted-by":"crossref","first-page":"e02349-16","DOI":"10.1128\/AAC.02349-16","article-title":"Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United States","volume":"61","author":"Satlin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025121011315096900_ofaf729-B54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fphar.2017.00364","article-title":"Antimicrobial activity and resistance: influencing factors","volume":"8","author":"Li","year":"2017","journal-title":"Front Pharmacol"},{"key":"2025121011315096900_ofaf729-B55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/1120009X.2020.1786634","article-title":"The role of PK\/PD\u2013based strategies to preserve new molecules against multi-drug resistant gram-negative strains","volume":"32","author":"Adembri","year":"2020","journal-title":"J Chemother"},{"key":"2025121011315096900_ofaf729-B56","doi-asserted-by":"crossref","first-page":"10.1128\/msystems.00783-20","DOI":"10.1128\/mSystems.00783-20","article-title":"Emerging transcriptional and genomic mechanisms mediating carbapenem and polymyxin resistance in Enterobacteriaceae: a systematic review of current reports","volume":"5","author":"Mmatli","year":"2020","journal-title":"mSystems"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf729\/65661541\/ofaf729.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/12\/ofaf729\/65661541\/ofaf729.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/12\/ofaf729\/65661541\/ofaf729.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T16:32:06Z","timestamp":1765384326000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf729\/8361828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf729","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,26]]},"article-number":"ofaf729"}}